BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 36340608)

  • 1. ABCG2, CD44 and SOX9 are increased with the acquisition of drug resistance and involved in cancer stem cell activities in head and neck squamous cell carcinoma cells.
    Murakami K; Umemura N; Adachi M; Motoki M; Ohkoshi E
    Exp Ther Med; 2022 Dec; 24(6):722. PubMed ID: 36340608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer stem cell mediated acquired chemoresistance in head and neck cancer can be abrogated by aldehyde dehydrogenase 1 A1 inhibition.
    Kulsum S; Sudheendra HV; Pandian R; Ravindra DR; Siddappa G; R N; Chevour P; Ramachandran B; Sagar M; Jayaprakash A; Mehta A; Kekatpure V; Hedne N; Kuriakose MA; Suresh A
    Mol Carcinog; 2017 Feb; 56(2):694-711. PubMed ID: 27380877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD44-negative cells in head and neck squamous carcinoma also have stem-cell like traits.
    Oh SY; Kang HJ; Kim YS; Kim H; Lim YC
    Eur J Cancer; 2013 Jan; 49(1):272-80. PubMed ID: 22770891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expansion and characterization of cancer stem-like cells in squamous cell carcinoma of the head and neck.
    Okamoto A; Chikamatsu K; Sakakura K; Hatsushika K; Takahashi G; Masuyama K
    Oral Oncol; 2009 Jul; 45(7):633-9. PubMed ID: 19027347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Up-regulation of Histone Methyltransferase, DOT1L, by Matrix Hyaluronan Promotes MicroRNA-10 Expression Leading to Tumor Cell Invasion and Chemoresistance in Cancer Stem Cells from Head and Neck Squamous Cell Carcinoma.
    Bourguignon LY; Wong G; Shiina M
    J Biol Chem; 2016 May; 291(20):10571-85. PubMed ID: 27002147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deregulation of the miR-222-ABCG2 regulatory module in tongue squamous cell carcinoma contributes to chemoresistance and enhanced migratory/invasive potential.
    Zhao L; Ren Y; Tang H; Wang W; He Q; Sun J; Zhou X; Wang A
    Oncotarget; 2015 Dec; 6(42):44538-50. PubMed ID: 26517090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SOX9 enhances sorafenib resistance through upregulating ABCG2 expression in hepatocellular carcinoma.
    Wang M; Wang Z; Zhi X; Ding W; Xiong J; Tao T; Yang Y; Zhang H; Zi X; Zhou W; Huang G
    Biomed Pharmacother; 2020 Sep; 129():110315. PubMed ID: 32554246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyaluronan-CD44v3 interaction with Oct4-Sox2-Nanog promotes miR-302 expression leading to self-renewal, clonal formation, and cisplatin resistance in cancer stem cells from head and neck squamous cell carcinoma.
    Bourguignon LY; Wong G; Earle C; Chen L
    J Biol Chem; 2012 Sep; 287(39):32800-24. PubMed ID: 22847005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated expression of Nrf2 mediates multidrug resistance in CD133
    Lu BC; Li J; Yu WF; Zhang GZ; Wang HM; Ma HM
    Oncol Lett; 2016 Dec; 12(6):4333-4338. PubMed ID: 28101198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cisplatin-resistant head and neck cancer cell line with cytoplasmic p53(mut) exhibits ATP-binding cassette transporter upregulation and high glutathione levels.
    Tonigold M; Rossmann A; Meinold M; Bette M; Märken M; Henkenius K; Bretz AC; Giel G; Cai C; Rodepeter FR; Beneš V; Grénman R; Carey TE; Lage H; Stiewe T; Neubauer A; Werner JA; Brendel C; Mandic R
    J Cancer Res Clin Oncol; 2014 Oct; 140(10):1689-704. PubMed ID: 24913304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SOX2 regulates self-renewal and tumorigenicity of stem-like cells of head and neck squamous cell carcinoma.
    Lee SH; Oh SY; Do SI; Lee HJ; Kang HJ; Rho YS; Bae WJ; Lim YC
    Br J Cancer; 2014 Nov; 111(11):2122-30. PubMed ID: 25321191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alteration of cancer stem cell-like phenotype by histone deacetylase inhibitors in squamous cell carcinoma of the head and neck.
    Chikamatsu K; Ishii H; Murata T; Sakakura K; Shino M; Toyoda M; Takahashi K; Masuyama K
    Cancer Sci; 2013 Nov; 104(11):1468-75. PubMed ID: 23992541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression of ABCB1, ABCG2, and KLF4 as putative indicators for paclitaxel resistance in human epithelial type 2 cells.
    Duz MB; Karatas OF
    Mol Biol Rep; 2021 Feb; 48(2):1393-1400. PubMed ID: 33506275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD44(high) /ALDH1(high) head and neck squamous cell carcinoma cells exhibit mesenchymal characteristics and GSK3β-dependent cancer stem cell properties.
    Seino S; Shigeishi H; Hashikata M; Higashikawa K; Tobiume K; Uetsuki R; Ishida Y; Sasaki K; Naruse T; Rahman MZ; Ono S; Simasue H; Ohta K; Sugiyama M; Takechi M
    J Oral Pathol Med; 2016 Mar; 45(3):180-8. PubMed ID: 26399460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-Met pathway promotes self-renewal and tumorigenecity of head and neck squamous cell carcinoma stem-like cell.
    Lim YC; Kang HJ; Moon JH
    Oral Oncol; 2014 Jul; 50(7):633-9. PubMed ID: 24835851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of ATP-binding cassette transporter proteins in multidrug resistance of head and neck squamous cell carcinoma.
    Guan GF; Zhang DJ; Zheng Y; Wen LJ; Yu DJ; Lu YQ; Zhao Y
    Oncol Lett; 2015 Aug; 10(2):631-636. PubMed ID: 26622545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sonic hedgehog-glioma associated oncogene homolog 1 signaling enhances drug resistance in CD44(+)/Musashi-1(+) gastric cancer stem cells.
    Xu M; Gong A; Yang H; George SK; Jiao Z; Huang H; Jiang X; Zhang Y
    Cancer Lett; 2015 Dec; 369(1):124-33. PubMed ID: 26276718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and characterization of CD133
    Wang J; Wu Y; Gao W; Li F; Bo Y; Zhu M; Fu R; Liu Q; Wen S; Wang B
    J Cancer; 2017; 8(3):497-506. PubMed ID: 28261352
    [No Abstract]   [Full Text] [Related]  

  • 19. ABCG2 is a potential marker of tumor-initiating cells in breast cancer.
    Sicchieri RD; da Silveira WA; Mandarano LR; de Oliveira TM; Carrara HH; Muglia VF; de Andrade JM; Tiezzi DG
    Tumour Biol; 2015 Dec; 36(12):9233-43. PubMed ID: 26091795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer stem cells enrichment with surface markers CD271 and CD44 in human head and neck squamous cell carcinomas.
    Elkashty OA; Abu Elghanam G; Su X; Liu Y; Chauvin PJ; Tran SD
    Carcinogenesis; 2020 Jun; 41(4):458-466. PubMed ID: 31742606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.